Literature DB >> 26151416

Cardiac fibroblasts as sentinel cells in cardiac tissue: Receptors, signaling pathways and cellular functions.

G Díaz-Araya1, R Vivar2, C Humeres2, P Boza2, S Bolivar2, C Muñoz2.   

Abstract

Cardiac fibroblasts (CF) not only modulate extracellular matrix (ECM) proteins homeostasis, but also respond to chemical and mechanical signals. CF express a variety of receptors through which they modulate the proliferation/cell death, autophagy, adhesion, migration, turnover of ECM, expression of cytokines, chemokines, growth factors and differentiation into cardiac myofibroblasts (CMF). Differentiation of CF to CMF involves changes in the expression levels of various receptors, as well as, changes in cell phenotype and their associated functions. CF and CMF express the β2-adrenergic receptor, and its stimulation activates PKA and EPAC proteins, which differentially modulate the CF and CMF functions mentioned above. CF and CMF also express different levels of Angiotensin II receptors, in particular, AT1R activation increases collagen synthesis and cell proliferation, but its overexpression activates apoptosis. CF and CMF express different levels of B1 and B2 kinin receptors, whose stimulation by their respective agonists activates common signaling transduction pathways that decrease the synthesis and secretion of collagen through nitric oxide and prostacyclin I2 secretion. Besides these classical functions, CF can also participate in the inflammatory response of cardiac repair, through the expression of receptors commonly associated to immune cells such as Toll like receptor 4, NLRP3 and interferon receptor. The activation by their respective agonists modulates the cellular functions already described and the release of cytokines and chemokines. Thus, CF and CMF act as sentinel cells responding to a plethora of stimulus, modifying their own behavior, and that of neighboring cells.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac fibroblast; Cellular functions; Cytokines; Receptors; Sentinel cells

Mesh:

Substances:

Year:  2015        PMID: 26151416     DOI: 10.1016/j.phrs.2015.07.001

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  23 in total

1.  Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro.

Authors:  Aimeé Salas-Hernández; Claudio Espinoza-Pérez; Raúl Vivar; Jenaro Espitia-Corredor; José Lillo; Pablo Parra-Flores; Carlos F Sánchez-Ferrer; Concepción Peiró; Guillermo Díaz-Araya
Journal:  Mol Biol Rep       Date:  2021-01-18       Impact factor: 2.316

2.  Silencing or not silencing p63 in cardiac fibroblast, risks and benefits.

Authors:  Guillermo Díaz-Araya; Jenaro Antonio Espitia-Corredor
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 3.  Cardiac sympathetic innervation, from a different point of (re)view.

Authors:  Tania Zaglia; Marco Mongillo
Journal:  J Physiol       Date:  2017-06-15       Impact factor: 5.182

4.  PLEKHM2 mutation leads to abnormal localization of lysosomes, impaired autophagy flux and associates with recessive dilated cardiomyopathy and left ventricular noncompaction.

Authors:  Emad Muhammad; Aviva Levitas; Sonia R Singh; Alex Braiman; Rivka Ofir; Sharon Etzion; Val C Sheffield; Yoram Etzion; Lucie Carrier; Ruti Parvari
Journal:  Hum Mol Genet       Date:  2015-10-12       Impact factor: 6.150

5.  Angiotensin II Triggers NLRP3 Inflammasome Activation by a Ca2+ Signaling-Dependent Pathway in Rat Cardiac Fibroblast Ang-II by a Ca2+-Dependent Mechanism Triggers NLRP3 Inflammasome in CF.

Authors:  Jenaro Antonio Espitia-Corredor; Pía Boza; Claudio Espinoza-Pérez; José Miguel Lillo; Constanza Rimassa-Taré; Víctor Machuca; José Miguel Osorio-Sandoval; Raúl Vivar; Samir Bolivar; Viviana Pardo-Jiménez; Carlos Félix Sánchez-Ferrer; Concepción Peiró; Guillermo Díaz-Araya
Journal:  Inflammation       Date:  2022-07-22       Impact factor: 4.657

Review 6.  The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis.

Authors:  Jiwen Fan; Meng Ren; Binay Kumar Adhikari; Haodong Wang; Yuquan He
Journal:  J Inflamm Res       Date:  2022-07-07

Review 7.  Computational modeling of cardiac fibroblasts and fibrosis.

Authors:  Angela C Zeigler; William J Richardson; Jeffrey W Holmes; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2015-12-01       Impact factor: 5.000

8.  ZYZ-168 alleviates cardiac fibrosis after myocardial infarction through inhibition of ERK1/2-dependent ROCK1 activation.

Authors:  Shanshan Luo; Tran Ba Hieu; Fenfen Ma; Ying Yu; Zhonglian Cao; Minjun Wang; Weijun Wu; Yicheng Mao; Peter Rose; Betty Yuen-Kwan Law; Yi Zhun Zhu
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

9.  RNA sequencing indicates age-dependent shifts in the cardiac fibroblast transcriptome between fetal, neonatal, and adult developmental ages.

Authors:  Luke R Perreault; Thanh T Le; Madeleine J Oudin; Lauren D Black
Journal:  Physiol Genomics       Date:  2021-07-19       Impact factor: 4.297

Review 10.  Cartilage Regeneration in Human with Adipose Tissue-Derived Stem Cells: Current Status in Clinical Implications.

Authors:  Jaewoo Pak; Jung Hun Lee; Wiwi Andralia Kartolo; Sang Hee Lee
Journal:  Biomed Res Int       Date:  2016-01-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.